PYPD
Polypid Ltd

832
Loading...
Loading...
News
all
press releases
PolyPid Ends Equity Sales Agreement, No Penalties Incurred
PolyPid (PYPD) has released an update. PolyPid Ltd. has officially notified Cantor Fitzgerald of its decision to end their Controlled Equity Offeri...
TipRanks Financial Blog·1y ago
News Placeholder
More News
News Placeholder
PolyPid to Participate in Barclays 26th Annual Global Healthcare Conference
PETACH TIKVA,Israel, Feb. 28, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD), ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...
Globe Newswire·2y ago
News Placeholder
PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript
PolyPid Ltd (PYPD) Q4 2023 Earnings Call Transcript...
SeekingAlpha·2y ago
News Placeholder
PolyPid GAAP EPS of -$3.97 misses by $1.18
PolyPid GAAP EPS of -$3.97 misses by $1.18...
SeekingAlpha.com: All News·2y ago
News Placeholder
PolyPid Provides Corporate Update and Reports Fourth Quarter and Full Year 2023 Financial Results
More Than 100 Patients Enrolled in Ongoing SHIELD II Phase 3 Trial of D-PLEX100 for the Prevention of Abdominal Colorectal Surgical Site Infections Unblinded Interim Analysis to be Conducted Once...
Globe Newswire·2y ago
News Placeholder
PolyPid Announces Enrollment of the 100th Patient in the Ongoing SHIELD II Phase 3 Trial
Approximately 40 Centers Currently Open Unblinded Interim Analysis to be Conducted Once Approximately 400 Patients Complete Their 30-Day Follow-up; Top-line Results Expected in Second Half of 2024...
Globe Newswire·2y ago
News Placeholder
PolyPid files to sell 6.74M ordinary shares for holders
See the rest of the story here. thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...
The Fly·2y ago
News Placeholder
PolyPid to Report Fourth Quarter and Full-Year 2023 Financial Results and Operational Highlights on February 14, 2024
PETACH TIKVA,Israel, Jan. 31, 2024 (GLOBE NEWSWIRE) -- PolyPid Ltd. (Nasdaq: PYPD) ( PolyPid or the Company ), a late-stage biopharma company aiming to improve surgical outcomes, today...
Globe Newswire·2y ago
News Placeholder
PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM) Head to Head Comparison
PolyPid (NASDAQ:PYPD Get Free Report) and Assure (NASDAQ:IONM Get Free Report) are both small-cap medical companies, but which is the superior business? We will compare the two...
Zolmax·2y ago
News Placeholder
Reviewing PolyPid (NASDAQ:PYPD) and Assure (NASDAQ:IONM)
Assure (NASDAQ:IONM Get Free Report) and PolyPid (NASDAQ:PYPD Get Free Report) are both small-cap medical companies, but which is the better business? We will compare the two...
Ticker Report·2y ago

Latest PYPD News

View

Advertisement. Remove ads.

Advertisement. Remove ads.